Cholangiocarcinoma: fusions in FGFR2 detected in liquid biopsy

被引：0
|
作者：
Patriarca, M. E. [1 ]
Coma, M. I. [1 ]
Naranjo Hans, D. [1 ]
Fernandez Rodriguez, M. C. [1 ]
Bellosillo, B. [1 ]
Visa Turmo, L. [1 ]
Lloveras, B. [1 ]
机构：
[1] Hosp Mar Parc Salut Mar, Dept Pathol, Barcelona, Spain
来源：
VIRCHOWS ARCHIV | 2022年 / 481卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
E-PS-07-02
引用
收藏
页码：S245 / S246
页数：2
相关论文
共 50 条
  • [1] Combination therapies for targeting FGFR2 fusions in cholangiocarcinoma
    Saborowski, Anna
    Vogel, Arndt
    Segatto, Oreste
    TRENDS IN CANCER, 2022, 8 (02) : 83 - 86
  • [2] Infigratinib in pretreated cholangiocarcinoma with FGFR2 fusions or rearrangements
    Neuzillet, Cindy
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (10): : 773 - 775
  • [3] FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma
    Cao, Zi
    Yang, Yichen
    Liu, Shasha
    Sun, Lin
    Liu, Yanxue
    Luo, Ye
    Wang, Jian
    Sun, Yan
    JOURNAL OF GASTROENTEROLOGY, 2025, 60 (02) : 235 - 246
  • [4] A pilot study of ponatinib in cholangiocarcinoma patients with FGFR2 fusions.
    DeLeon, Thomas
    Alberts, Steven R.
    McWilliams, Robert R.
    Hubbard, Joleen Marie
    Ahn, Daniel H.
    Bekaii-Saab, Tanios S.
    Mody, Kabir
    Roberts, Lewis R.
    Salomao, Marcela
    Kipp, Benjamin
    Halfdanarson, Thorvardur Ragnar
    Murtaza, Muhammed
    Ramanathan, Ramesh K.
    Dueck, Amylou C.
    Borad, Mitesh J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [5] Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
    Neumann, Olaf
    Burn, Timothy C.
    Allgaeuer, Michael
    Ball, Markus
    Kirchner, Martina
    Albrecht, Thomas
    Volckmar, Anna-Lena
    Beck, Susanne
    Endris, Volker
    Goldschmid, Hannah
    Lehmann, Ulrich
    Seker-Cin, Huriye
    Uhrig, Sebastian
    Roessler, Stephanie
    Budczies, Jan
    Froehling, Stefan
    Longerich, Thomas
    Wagner, Alex H.
    Vogel, Arndt
    Schirmacher, Peter
    Stenzinger, Albrecht
    Kazdal, Daniel
    BRITISH JOURNAL OF CANCER, 2022, 127 (08) : 1540 - 1549
  • [6] Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing
    Olaf Neumann
    Timothy C. Burn
    Michael Allgäuer
    Markus Ball
    Martina Kirchner
    Thomas Albrecht
    Anna-Lena Volckmar
    Susanne Beck
    Volker Endris
    Hannah Goldschmid
    Ulrich Lehmann
    Huriye Seker-Cin
    Sebastian Uhrig
    Stephanie Roessler
    Jan Budczies
    Stefan Fröhling
    Thomas Longerich
    Alex H. Wagner
    Arndt Vogel
    Peter Schirmacher
    Albrecht Stenzinger
    Daniel Kazdal
    British Journal of Cancer, 2022, 127 : 1540 - 1549
  • [7] Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma
    Kongpetch, Sarinya
    Jusakul, Apinya
    Lim, Jing Quan
    Ng, Cedric Chuan Young
    Chan, Jason Yongsheng
    Rajasegaran, Vikneswari
    Lim, Tse Hui
    Lim, Kiat Hon
    Choo, Su Pin
    Dima, Simona
    Popescu, Irinel
    Duda, Dan G.
    Kukongviriyapan, Veerapol
    Khuntikeo, Narong
    Pairojkul, Chawalit
    Rozen, Steven G.
    Tan, Patrick
    Teh, Bin Tean
    JCO GLOBAL ONCOLOGY, 2020, 6 : 628 - 638
  • [8] Clinical outcomes and genomic evolution of FGFR2 fusions/rearrangements in intrahepatic cholangiocarcinoma
    Cham, Brent B.
    Lee, Sunyoung S.
    CANCER RESEARCH, 2022, 82 (12)
  • [9] FGFR2 Inhibition in Cholangiocarcinoma
    Vogel, Arndt
    Segatto, Oreste
    Stenzinger, Albrecht
    Saborowski, Anna
    ANNUAL REVIEW OF MEDICINE, 2023, 74 : 293 - 306
  • [10] Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test
    Ishido, Shun
    Tamaki, Nobuharu
    Inada, Kento
    Itakura, Jun
    Takahashi, Yuka
    Uchihara, Naoki
    Suzuki, Keito
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Matsumoto, Hiroaki
    Nobusawa, Tsubasa
    Keitoku, Taisei
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Kurosaki, Masayuki
    Izumi, Namiki
    CLINICAL CASE REPORTS, 2023, 11 (07):
12345